These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5134260)

  • 21. A study of carbohydrate metabolism in postnecrotic cirrhosis liver.
    Yeung RT; Wang CC
    Gut; 1974 Nov; 15(11):907-12. PubMed ID: 4455570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucagon in intravenous glucose tolerance.
    Turner DA; Audhya TK; Cramp DG; Holdsworth CD; McIntyre N
    Br Med J; 1967 Oct; 4(5572):145-6. PubMed ID: 6053979
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels.
    Holdsworth CD; Nye L; King E
    Gut; 1972 Jan; 13(1):58-63. PubMed ID: 5060671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 25. Pancreatic compartmentalization of insulin. Evidence for pituitary control.
    Merimee TJ; Fineberg SE
    Diabetes; 1973 Jan; 22(1):25-9. PubMed ID: 4683793
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressed tolbutamide-induced insulin response in subjects treated with propranolol.
    Massara F; Strumia E; Camanni F; Molinatti GM
    Diabetologia; 1971 Aug; 7(4):287-9. PubMed ID: 5093710
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.
    Joffe BI; Bank S; Jackson WP; Vinik AI; Keller P
    Diabetes; 1969 Jul; 18(7):499-501. PubMed ID: 5795033
    [No Abstract]   [Full Text] [Related]  

  • 29. The spectrum of plasma insulin responses in middle-aged and old non-obese diabetics with various degrees of metabolic derangement.
    Johansen K
    Acta Med Scand; 1973; 194(3):157-64. PubMed ID: 4746522
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of plasma free fatty acids in the control of insulin secretion in man.
    Balasse EO; Ooms HA
    Diabetologia; 1973 Apr; 9(2):145-51. PubMed ID: 4577294
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of sulfonylureas to suppress plasma glucagon in man.
    Pek S; Fajans SS; Floyd JC; Knopf RF; Conn JW
    Diabetes; 1972 Apr; 21(4):216-23. PubMed ID: 5017378
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glucagon-induced hyperglycemia as a measure of liver function].
    Ege P; Jacobsen M
    Nord Med; 1971; 86(49):1475-7. PubMed ID: 5137026
    [No Abstract]   [Full Text] [Related]  

  • 33. [Disorders of glucose tolerance in 2600 histologically confirmed acute and chronic liver patients (author's transl)].
    Mütting D; Kaufmann M
    MMW Munch Med Wochenschr; 1975 Oct; 117(42):1689-94. PubMed ID: 810695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
    Baker IA; Jarrett RJ
    Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
    Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
    Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
    [No Abstract]   [Full Text] [Related]  

  • 36. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH; Mahler RF; Hales CN
    Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of blood sugar, pyruvate and serum ILA (rat hemidiaphragm) to intravenous sodium tolbutamide in normal and diabetic subjects.
    Rastogi GK
    Indian J Med Res; 1970 Apr; 58(4):438-43. PubMed ID: 5506667
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of age on serum insulin level following intravenous administration of glucose, tolbutamide and glucagon].
    Sorge F; Passarge E; Neuhaus GA
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1393-6. PubMed ID: 347781
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.
    Ryan WG; Nibbe AF; Schwartz TB
    Lancet; 1967 Jun; 1(7502):1255-6. PubMed ID: 4165041
    [No Abstract]   [Full Text] [Related]  

  • 40. Mild diabetes in young subjects. Clinical aspects and plasma insulin response pattern.
    Johansen K
    Acta Med Scand; 1973; 193(1-2):23-33. PubMed ID: 4705081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.